Viewing Study NCT05025956


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-01-05 @ 6:03 PM
Study NCT ID: NCT05025956
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-16
First Post: 2021-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
Sponsor: Steadman Philippon Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Femoroacetabular Impingement View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FAI Labral tear Fisetin Losartan View